Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iSpecimen (ISPC) Shares Outstanding (Weighted Average): 2020-2025

Historic Shares Outstanding (Weighted Average) for iSpecimen (ISPC) over the last 5 years, with Sep 2025 value amounting to $5.5 million.

  • iSpecimen's Shares Outstanding (Weighted Average) rose 745.89% to $5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year increase of 745.89%. This contributed to the annual value of $962,637 for FY2024, which is 112.13% up from last year.
  • iSpecimen's Shares Outstanding (Weighted Average) amounted to $5.5 million in Q3 2025, which was up 121.85% from $2.5 million recorded in Q2 2025.
  • Over the past 5 years, iSpecimen's Shares Outstanding (Weighted Average) peaked at $5.5 million during Q3 2025, and registered a low of $312,018 during Q1 2021.
  • Over the past 3 years, iSpecimen's median Shares Outstanding (Weighted Average) value was $498,948 (recorded in 2024), while the average stood at $1.2 million.
  • Data for iSpecimen's Shares Outstanding (Weighted Average) shows a peak YoY soared of 745.89% (in 2025) over the last 5 years.
  • iSpecimen's Shares Outstanding (Weighted Average) (Quarterly) stood at $436,477 in 2021, then increased by 0.36% to $438,050 in 2022, then rose by 3.59% to $453,790 in 2023, then spiked by 112.13% to $962,637 in 2024, then spiked by 745.89% to $5.5 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $5.5 million in Q3 2025, compared to $2.5 million in Q2 2025 and $962,637 in Q1 2025.